APOE Protein (Myc-DYKDDDDK Tag)

N° du produit ABIN2714829

Cette protéine Recombinant APOE est produite dans HEK-293 Cells. Il y a 1 publication disponible.

Aperçu rapide pour APOE Protein (Myc-DYKDDDDK Tag) (ABIN2714829)

Antigène: APOE (Apolipoprotein E (APOE))

Type de proteíne: Recombinant

Origine: Humain

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Pureté: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Détail du produit

Purification/Conjugué: Cette APOE protéine est marqué à la Myc-DYKDDDDK Tag.

Attributs du produit:

• Recombinant human Apolipoprotein E / Apo E protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Information d'application

Indications d'application: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Commentaires:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Stockage

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Stock: -80 °C

Stockage commentaire: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Référence

Pan, Zhou, Mahsut, Rohm, Berejnaia, Price, Chen, Castro-Perez, Lassman, McLaren, Conway, Jensen, Thomas, Reyes-Soffer, Ginsberg, Gutstein, Cleary, Previs, Roddy: "Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS." dans: Journal of lipid research, Vol. 55, Issue 6, pp. 1179-87, (2016) (PubMed).

Détail du antigène

Antigène: APOE (Apolipoprotein E (APOE))

Autre désignation: Apolipoprotein E,apo E

Sujet: The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants.

Poids moléculaire: 34.2 kDa

NCBI Accession: NP_000032

Pathways: Regulation of Cell Size, Lipid Metabolism